James R. Klinger

Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial

J. A. Kline, Kristen E. Nordenholz, D. Mark Courtney et al. · Journal of Thrombosis and Haemostasis · 2014 · 284 citations

Medicine, Pharmacotherapy, Surgery +12

Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice

Jason M. Aliotta, Mandy Pereira, Sicheng Wen et al. · Cardiovascular Research · 2016 · 253 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry

Kevin Y. Chang, Sue Duval, David B. Badesch et al. · Journal of the American Heart Association · 2022 · 234 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza et al. · The Lancet Respiratory Medicine · 2021 · 161 citations

Medicine, Pharmacology, Pharmacotherapy +9

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors

Marius M. Hoeper, Gérald Simonneau, Paul A. Corris et al. · European Respiratory Journal · 2017 · 156 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17